Catalio Capital Management
North America, New York, United States, New York
Description
Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies.
Investor Profile
Catalio Capital Management has made 80 investments, with 14 in the past 12 months and 29% as lead.
Stage Focus
- Series A (28%)
- Series B (24%)
- Series C (14%)
- Series Unknown (13%)
- Series D (8%)
- Post Ipo Equity (4%)
- Series E (4%)
- Seed (3%)
- Debt Financing (3%)
- Private Equity (1%)
Country Focus
- United States (90%)
- France (3%)
- Switzerland (3%)
- Germany (3%)
- Israel (1%)
- Australia (1%)
'/%3e%3c/defs%3e%3cpath fill='%23012169' d='M0 0h10080v5040H0z'/%3e%3cpath stroke='%23fff' stroke-width='.6' d='m0 0 6 3m0-3L0 3' clip-path='url(%23b)' transform='scale(840)'/%3e%3cpath stroke='%23e4002b' stroke-width='.4' d='m0 0 6 3m0-3L0 3' clip-path='url(%23c)' transform='scale(840)'/%3e%3cpath stroke='%23fff' stroke-width='840' d='M2520 0v2520M0 1260h5040'/%3e%3cpath stroke='%23e4002b' stroke-width='504' d='M2520 0v2520M0 1260h5040'/%3e%3cg fill='%23fff'%3e%3cuse xlink:href='%23d' x='2520' y='3780'/%3e%3cuse xlink:href='%23a' x='7560' y='4200'/%3e%3cuse xlink:href='%23a' x='6300' y='2205'/%3e%3cuse xlink:href='%23a' x='7560' y='840'/%3e%3cuse xlink:href='%23a' x='8680' y='1869'/%3e%3cuse xlink:href='%23e' x='8064' y='2730'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Medical
- Pharmaceutical
- Health Diagnostics
- Biopharma
- Medical Device
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
